ReviewThe Journal of clinical investigation2020
State of the art in CAR T cell therapy for CD19+ B cell malignancies.
Matthew J Frigault et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this paperpooled ittrialcites it